×

What are you searching for?




Pharmaceuticals

4 Min read

COVID-19 DISRUPTION IN CHINA BEYOND APRIL WILL MAKE INDIAN PHARMACEUTICALS WORRIED

Published On 14 Feb 2020 03:22 PM


SHARE THIS ARTICLE  


Highlights:

  • India imports 70% of API from China
  • Till April 2020 Indian pharma-sector stocked with API
  • Beyond April 2020, it will be a worrisome state for India

Indian Pharmaceutical companies will have to bear the cost of China’s COVID-19 disruption.

In the global economy, China has a vital role to play. With corona virus almost breaking China’s back, the rest of t....


Tags : API, Indian pharma, Corona virus outbreak, COVID-19,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)